Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lythrum salicaria (purple loosestrife) is a perennial herbaceous plant in the Lythraceae family. Traditionally used in European and Asian herbal medicine for centuries[4], its main medicinal applications include treatment of gastrointestinal tract ailments such as diarrhea and dysentery[1][3][4]. The plant contains polyphenols (notably C-glucosidic ellagitannins and flavonoids), tannins (especially the compound salicarin), anthocyanins and other phytochemicals that contribute to its pharmacological effects including antidiarrheal[1][4], antimicrobial[1][5], antifungal[2][5], anti-inflammatory[1][3][4], antioxidant[1][4] and astringent actions. It has also been used topically for skin conditions like eczema or wounds; as a styptic for bleeding; for varicose veins and hemorrhoids; as well as in traditional remedies for menstrual problems and mouth/throat sores. Modern research supports some of these activities but robust clinical evidence is lacking.[3][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lythrum salicaria.